Literature DB >> 21251557

Pneumocystis jirovecii testing by real-time polymerase chain reaction and direct examination among immunocompetent and immunosuppressed patient groups and correlation to disease specificity.

John W Wilson1, Andew H Limper, Thomas E Grys, Theresa Karre, Nancy L Wengenack, Matthew J Binnicker.   

Abstract

We used real-time polymerase chain reaction (PCR) targeting the cdc2 gene and direct fluorescent microscopy examination (DFME) to evaluate the prevalence of Pneumocystis jirovecii among immunocompetent patients without clinical pulmonary infection and immunosuppressed patients evaluated for opportunistic pulmonary infections. Among 102 bronchoalveolar lavage samples collected from immunocompetent patients without infection, none tested positive for P. jirovecii by either DFME or real-time PCR despite the presence of other comorbidities. Among patients with suspected pulmonary infection and tested with either assay, real-time PCR produced a higher number of positive results compared to DFME and increased P. jirovecii detection by 7% when added to DFME-negative samples. Real-time PCR may have increased sensitivity for P. jirovecii detection over DFME and decrease the risk of sample contamination compared to conventional and nested PCR. The use of single-copy gene targets (e.g., cdc2) may lower the rate of "colonization" detection and confer a high predictive value for Pneumocystis pneumonia. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21251557      PMCID: PMC6855182          DOI: 10.1016/j.diagmicrobio.2010.10.021

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  33 in total

1.  Pulmonary colonization with Pneumocystis carinii in human immunodeficiency virus-negative patients: assessing risk with blood CD4+ T cell counts.

Authors:  G Nevez; C Raccurt; P Vincent; V Jounieaux; E Dei-Cas
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

2.  Systemic inflammation in patients with chronic obstructive pulmonary disease who are colonized with Pneumocystis jiroveci.

Authors:  Enrique J Calderón; Laura Rivero; Nieves Respaldiza; Rubén Morilla; Marco A Montes-Cano; Vicente Friaza; Fernando Muñoz-Lobato; José M Varela; Francisco J Medrano; Carmen de la Horra
Journal:  Clin Infect Dis       Date:  2007-06-06       Impact factor: 9.079

3.  Pneumocystis colonization in older adults and diagnostic yield of single versus paired noninvasive respiratory sampling.

Authors:  Sergio L Vargas; Patricia Pizarro; Mónica López-Vieyra; Patricia Neira-Avilés; Rebeca Bustamante; Carolina A Ponce
Journal:  Clin Infect Dis       Date:  2010-02-01       Impact factor: 9.079

4.  Pneumocystis carinii carriage among cystic fibrosis patients, as detected by nested PCR.

Authors:  A Sing; A M Geiger; M Hogardt; J Heesemann
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

5.  High seroprevalence of Pneumocystis infection in Spanish children.

Authors:  N Respaldiza; F J Medrano; A C Medrano; J M Varela; C de la Horra; M Montes-Cano; S Ferrer; I Wichmann; D Gargallo-Viola; E J Calderon
Journal:  Clin Microbiol Infect       Date:  2004-11       Impact factor: 8.067

6.  Parasitologic and serologic observations of infection with Pneumocystis in humans.

Authors:  J H Meuwissen; I Tauber; A D Leeuwenberg; P J Beckers; M Sieben
Journal:  J Infect Dis       Date:  1977-07       Impact factor: 5.226

7.  Development and evaluation of a rapid and simple procedure for detection of Pneumocystis carinii by PCR.

Authors:  C P Cartwright; N A Nelson; V J Gill
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

8.  Development and evaluation of a real-time PCR assay for detection of Pneumocystis jirovecii DNA in bronchoalveolar lavage fluid of HIV-infected patients.

Authors:  J F Huggett; M S Taylor; G Kocjan; H E Evans; S Morris-Jones; V Gant; T Novak; A M Costello; A Zumla; R F Miller
Journal:  Thorax       Date:  2007-08-10       Impact factor: 9.139

9.  Pneumocystis colonization is highly prevalent in the autopsied lungs of the general population.

Authors:  Carolina A Ponce; Myriam Gallo; Rebeca Bustamante; Sergio L Vargas
Journal:  Clin Infect Dis       Date:  2010-02-01       Impact factor: 9.079

Review 10.  Autoimmune inflammatory disorders, systemic corticosteroids and pneumocystis pneumonia: a strategy for prevention.

Authors:  Evin Sowden; Andrew J Carmichael
Journal:  BMC Infect Dis       Date:  2004-10-16       Impact factor: 3.090

View more
  30 in total

1.  Clinical Performance of (1,3) Beta-D Glucan for the Diagnosis of Pneumocystis Pneumonia (PCP) in Cancer Patients Tested With PCP Polymerase Chain Reaction.

Authors:  Sejal Morjaria; John Frame; Alexandra Franco-Garcia; Alexander Geyer; Mini Kamboj; N Esther Babady
Journal:  Clin Infect Dis       Date:  2019-09-27       Impact factor: 9.079

2.  Low Risk of Pneumonia From Pneumocystis jirovecii Infection in Patients With Inflammatory Bowel Disease Receiving Immune Suppression.

Authors:  Thomas G Cotter; Nicola Gathaiya; Jelena Catania; Edward V Loftus; William J Tremaine; Larry M Baddour; W Scott Harmsen; Alan R Zinsmeister; William J Sandborn; Andrew H Limper; Darrell S Pardi
Journal:  Clin Gastroenterol Hepatol       Date:  2016-12-21       Impact factor: 11.382

3.  Validation of the MycAssay Pneumocystis kit for detection of Pneumocystis jirovecii in bronchoalveolar lavage specimens by comparison to a laboratory standard of direct immunofluorescence microscopy, real-time PCR, or conventional PCR.

Authors:  Lisa R McTaggart; Nancy L Wengenack; Susan E Richardson
Journal:  J Clin Microbiol       Date:  2012-03-14       Impact factor: 5.948

4.  Pneumocystis pneumonia in patients treated with rituximab.

Authors:  Isabel Martin-Garrido; Eva M Carmona; Ulrich Specks; Andrew H Limper
Journal:  Chest       Date:  2013-07       Impact factor: 9.410

5.  Detection, identification, and distribution of fungi in bronchoalveolar lavage specimens by use of multilocus PCR coupled with electrospray ionization/mass spectrometry.

Authors:  Jeong Hwan Shin; Raymond Ranken; Susan E Sefers; Robert Lovari; Criziel D Quinn; Shufang Meng; Heather E Carolan; Donna Toleno; Haijing Li; Jeong Nyeo Lee; Charles W Stratton; Christian Massire; Yi-Wei Tang
Journal:  J Clin Microbiol       Date:  2012-10-24       Impact factor: 5.948

6.  Development and evaluation of a real-time PCR assay for detection of Pneumocystis jirovecii on the fully automated BD MAX platform.

Authors:  Alexander H Dalpke; Marjeta Hofko; Stefan Zimmermann
Journal:  J Clin Microbiol       Date:  2013-05-15       Impact factor: 5.948

Review 7.  Infections after lung transplantation.

Authors:  Mario Nosotti; Paolo Tarsia; Letizia Corinna Morlacchi
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

Review 8.  Infections in the immunosuppressed host.

Authors:  M Patricia George; Henry Masur; Karen A Norris; Scott M Palmer; Cornelius J Clancy; John F McDyer
Journal:  Ann Am Thorac Soc       Date:  2014-08

9.  Incidence, clinical presentation, and outcomes of Pneumocystis pneumonia when utilizing Polymerase Chain Reaction-based diagnosis in patients with Hodgkin lymphoma.

Authors:  Jason N Barreto; Carrie A Thompson; Patrick M Wieruszewski; Amanda G Pawlenty; Kristin C Mara; Ashley L Potter; Pritish K Tosh; Andrew H Limper
Journal:  Leuk Lymphoma       Date:  2020-07-05

Review 10.  Advances in the diagnosis of fungal pneumonias.

Authors:  Bryan T Kelly; Kelly M Pennington; Andrew H Limper
Journal:  Expert Rev Respir Med       Date:  2020-04-21       Impact factor: 3.772

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.